These effects were associated with decreased lipid peroxidation (4-HNE), activation of Nrf2—and likely the endogenous antioxidant system—reduced AQP4 expression, which may mitigate cerebral edema, and enhanced NeuN and Akt expression. The gene discussed is RBFOX3; the disease is brain edema.